Dacă știința face parte din viața ta și vrei să afli care sunt studiile din spatele fiecărui material prezent în spitalul sau clinica de unde ai aflat informații despre gama HYLO EYE CARE, mai jos ai toate detaliile.
1. Monografia produsului, URSA PHARM; 2. Prospect produs, URSA PHARM; 3. Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model, Eric Carlson, Winston W.Y. Kao, and Abayomi Ogundele, JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 34, Number 4, 2018 Mary Ann Liebert, Inc. DOI: 10.1089/jop.2017.0080; 4. Hyaluronan, a Crucial Regulator of Inflammation, Aaron C. Petrey and Carol A. de la Motte, Front Immunol. 2014; 5: 101; 5. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells, Thierry Pauloin, Mélody Dutot, Francine Joly, Jean-Michel Warnet, and Patrice Rat, Mol Vis. 2009; 15: 577–583; 6. High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation, Anu S. Maharjan, Darrell Pilling, and Richard H. Gomer, PLoS One. 2011; 6(10): e26078; 7. High and low molecular weight hyaluronic acid differentially influence macrophage activation, Jamie E. Rayahin, Jason S. Buhrman, Yu Zhang, Timothy J. Koh, and Richard A. Gemeinhart,ACS Biomater Sci Eng. 2015 Jul 13; 1(7): 481–493; 8. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing of hyaluronan, Nakamura, M., Hikida, M., and Nakano, T. Curr. Eye Res. 11: 981–986, 1992; 9. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect, Camillieri, G., Bucolo, C., Rossi, S., and Drago, F. J. Ocul. Pharmacol. Ther. 20:548–553, 2004; 10. Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping, Daull, P., Feraille, L., Elena, PP., and Garrigue, JS. J. Ocul. Pharmacol. Ther. 32:109–118, 2016; 11. Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology Jaime M. Cyphert, Carol S. Trempus, and Stavros Garantziotis, Hindawi Publishing Corporation International Journal of Cell Biology Volume 2015, Article ID 563818, 8 pages; 12. M. Pattmöller, N. Szentmáry, T. Eppig, D. Groß, B. Seitz, Verträglichkeit von Hyaluronsäure zur Oberflächenpflege nach perforierender Keratoplastik, Klin Monbl Augenheilkd 2018; 235(01): 64-72 DOI: 10.1055/s-0042-116158
2. Monografia produsului, URSA PHARM; 2. Prospect produs, URSA PHARM; 3. Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model, Eric Carlson, Winston W.Y. Kao, and Abayomi Ogundele, JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 34, Number 4, 2018 Mary Ann Liebert, Inc. DOI: 10.1089/jop.2017.0080; 4. Hyaluronan, a Crucial Regulator of Inflammation, Aaron C. Petrey and Carol A. de la Motte, Front Immunol. 2014; 5: 101; 5. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells, Thierry Pauloin, Mélody Dutot, Francine Joly, Jean-Michel Warnet, and Patrice Rat, Mol Vis. 2009; 15: 577–583; 6. High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation, Anu S. Maharjan, Darrell Pilling, and Richard H. Gomer, PLoS One. 2011; 6(10): e26078; 7. High and low molecular weight hyaluronic acid differentially influence macrophage activation, Jamie E. Rayahin, Jason S. Buhrman, Yu Zhang, Timothy J. Koh, and Richard A. Gemeinhart,ACS Biomater Sci Eng. 2015 Jul 13; 1(7): 481–493; 8. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing of hyaluronan, Nakamura, M., Hikida, M., and Nakano, T. Curr. Eye Res. 11: 981–986, 1992; 9. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect, Camillieri, G., Bucolo, C., Rossi, S., and Drago, F. J. Ocul. Pharmacol. Ther. 20:548–553, 2004; 10. Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping, Daull, P., Feraille, L., Elena, PP., and Garrigue, JS. J. Ocul. Pharmacol. Ther. 32:109–118, 2016; 11. Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology Jaime M. Cyphert, Carol S. Trempus, and Stavros Garantziotis, Hindawi Publishing Corporation International Journal of Cell Biology Volume 2015, Article ID 563818, 8 pages; 12. Pattmöller M, Szentmáry N, Eppig T, Groß D, Seitz B., Safety of Hyaluronic Acid in Postoperative Treatment after Penetrating Keratoplasty; Klin Monbl Augenheilkd. 2018;235(1):64-72. doi:10.1055/s-0042-116158.
3. Monografia produsului, URSA PHARM; 2. Prospect produs, URSA PHARM; 3. Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model, Eric Carlson, Winston W.Y. Kao, and Abayomi Ogundele, JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 34, Number 4, 2018 Mary Ann Liebert, Inc. DOI: 10.1089/jop.2017.0080; 4. Hyaluronan, a Crucial Regulator of Inflammation, Aaron C. Petrey and Carol A. de la Motte, Front Immunol. 2014; 5: 101; 5. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells, Thierry Pauloin, Mélody Dutot, Francine Joly, Jean-Michel Warnet, and Patrice Rat, Mol Vis. 2009; 15: 577–583; 6. High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation, Anu S. Maharjan, Darrell Pilling, and Richard H. Gomer, PLoS One. 2011; 6(10): e26078; 7. High and low molecular weight hyaluronic acid differentially influence macrophage activation, Jamie E. Rayahin, Jason S. Buhrman, Yu Zhang, Timothy J. Koh, and Richard A. Gemeinhart,ACS Biomater Sci Eng. 2015 Jul 13; 1(7): 481–493; 8. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing of hyaluronan, Nakamura, M., Hikida, M., and Nakano, T. Curr. Eye Res. 11: 981–986, 1992; 9. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect, Camillieri, G., Bucolo, C., Rossi, S., and Drago, F. J. Ocul. Pharmacol. Ther. 20:548–553, 2004; 10. Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping, Daull, P., Feraille, L., Elena, PP., and Garrigue, JS. J. Ocul. Pharmacol. Ther. 32:109–118, 2016; 11. Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology Jaime M. Cyphert, Carol S. Trempus, and Stavros Garantziotis, Hindawi Publishing Corporation International Journal of Cell Biology Volume 2015, Article ID 563818, 8 pages; 12. Ectoin, the natural stress-protection molecule, monografie, BitopAG; 13. Review Article Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface, Andreas Bilstein, Anja Heinrich, Anna Rybachuk and Ralph Mösges, Hindawi BioMed Research International Volume 2021, Article ID 8885032, 16 pages https://doi.org/10.1155/2021/8885032; 14. M. Pattmöller, N. Szentmáry, T. Eppig, D. Groß, B. Seitz, Verträglichkeit von Hyaluronsäure zur Oberflächenpflege nach perforierender Keratoplastik, Klin Monbl Augenheilkd 2018; 235(01): 64-72 DOI: 10.1055/s-0042-116158
4. Monografia produsului, URSA PHARM; 2. Prospect produs, URSA PHARM; 3. Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model, Eric Carlson, Winston W.Y. Kao, and Abayomi Ogundele, JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 34, Number 4, 2018 Mary Ann Liebert, Inc. DOI: 10.1089/jop.2017.0080; 4. Hyaluronan, a Crucial Regulator of Inflammation, Aaron C. Petrey and Carol A. de la Motte, Front Immunol. 2014; 5: 101; 5. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells, Thierry Pauloin, Mélody Dutot, Francine Joly, Jean-Michel Warnet, and Patrice Rat, Mol Vis. 2009; 15: 577–583; 6. High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation, Anu S. Maharjan, Darrell Pilling, and Richard H. Gomer, PLoS One. 2011; 6(10): e26078; 7. High and low molecular weight hyaluronic acid differentially influence macrophage activation, Jamie E. Rayahin, Jason S. Buhrman, Yu Zhang, Timothy J. Koh, and Richard A. Gemeinhart,ACS Biomater Sci Eng. 2015 Jul 13; 1(7): 481–493; 8. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing of hyaluronan, Nakamura, M., Hikida, M., and Nakano, T. Curr. Eye Res. 11: 981–986, 1992; 9. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect, Camillieri, G., Bucolo, C., Rossi, S., and Drago, F. J. Ocul. Pharmacol. Ther. 20:548–553, 2004; 10. Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping, Daull, P., Feraille, L., Elena, PP., and Garrigue, JS. J. Ocul. Pharmacol. Ther. 32:109–118, 2016; 11. Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology Jaime M. Cyphert, Carol S. Trempus, and Stavros Garantziotis, Hindawi Publishing Corporation International Journal of Cell Biology Volume 2015, Article ID 563818, 8 pages; 12. M. Pattmöller, N. Szentmáry, T. Eppig, D. Groß, B. Seitz, Verträglichkeit von Hyaluronsäure zur Oberflächenpflege nach perforierender Keratoplastik, Klin Monbl Augenheilkd 2018; 235(01): 64-72 DOI: 10.1055/s-0042-116158
5. Monografia produsului, URSA PHARM; 2. Prospect produs, URSA PHARM; 3. Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model, Eric Carlson, Winston W.Y. Kao, and Abayomi Ogundele, JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 34, Number 4, 2018 Mary Ann Liebert, Inc. DOI: 10.1089/jop.2017.0080; 4. Hyaluronan, a Crucial Regulator of Inflammation, Aaron C. Petrey and Carol A. de la Motte, Front Immunol. 2014; 5: 101; 5. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells, Thierry Pauloin, Mélody Dutot, Francine Joly, Jean-Michel Warnet, and Patrice Rat, Mol Vis. 2009; 15: 577–583; 6. High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation, Anu S. Maharjan, Darrell Pilling, and Richard H. Gomer, PLoS One. 2011; 6(10): e26078; 7. High and low molecular weight hyaluronic acid differentially influence macrophage activation, Jamie E. Rayahin, Jason S. Buhrman, Yu Zhang, Timothy J. Koh, and Richard A. Gemeinhart,ACS Biomater Sci Eng. 2015 Jul 13; 1(7): 481–493; 8. Concentration and molecular weight dependency of rabbit corneal epithelial wound healing of hyaluronan, Nakamura, M., Hikida, M., and Nakano, T. Curr. Eye Res. 11: 981–986, 1992; 9. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect, Camillieri, G., Bucolo, C., Rossi, S., and Drago, F. J. Ocul. Pharmacol. Ther. 20:548–553, 2004; 10. Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping, Daull, P., Feraille, L., Elena, PP., and Garrigue, JS. J. Ocul. Pharmacol. Ther. 32:109–118, 2016; 11. Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology Jaime M. Cyphert, Carol S. Trempus, and Stavros Garantziotis, Hindawi Publishing Corporation International Journal of Cell Biology Volume 2015, Article ID 563818, 8 pages; 12. Pattmöller M, Szentmáry N, Eppig T, Groß D, Seitz B., Safety of Hyaluronic Acid in Postoperative Treatment after Penetrating Keratoplasty; Klin Monbl Augenheilkd. 2018;235(1):64-72. doi:10.1055/s-0042-116158
6. Monografia produsului, URSA PHARM 2. Prospect produs, URSA PHARM 3. Steven P, Augustin AJ, Geerling G, et al. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease. J Ocul Pharmacol Ther. 2017;33(9):678-685. doi:10.1089/jop.2017.0042 4. Meinert H, Roy T. Semifluorinated alkanes–a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol. 2000;10(3):189-197. 5. Evaluation of the effectiveness of dry eye syndrome treatment using EvoTears – New drops containing Perfluorohexyloctane – Jamiołkowska i. Krix-jachym k. Rękas m. – Military institute of medicine, Ophthalmology Clinic. 6. Steven P, Scherer D, Krösser S, Beckert M, Cursiefen C, Kaercher T. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease–A Prospective, Multicenter Noninterventional Study. J Ocul Pharmacol Ther. 2015;31(8):498-503. doi:10.1089/jop.2015.0048 7. Tauber J, Wirta DL, Sall K, et al. A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease. Cornea. 2021;40(9):1132-1140. doi:10.1097/ICO.0000000000002622 8. Rabensteiner DF, Aminfar H, Boldin I, Schwantzer G, Horwath-Winter J. The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population. Acta Ophthalmol. 2018;96(6):e707-e711. doi:10.1111/aos. 13732 9. Delicado-Miralles, Miguel et al. “Deciphering the Action of Perfluorohexyloctane Eye Drops to Reduce Ocular Discomfort and Pain.” Frontiers in medicine vol. 8 709712. 26 Oct. 2021, doi:10.3389/fmed.2021.709712